The changing face of familial colorectal cancer

British Medical Journal

Volumn 330, Issue 7481, 2005, Pages 2-3

  Banerjea, Ayan ^a   Clark, Sue ^a   Dorudi, Sina ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; MICROSATELLITE DNA;

ADULT; CANCER DIAGNOSIS; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; DNA SEQUENCE; EDITORIAL; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; MICROSATELLITE INSTABILITY; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 11244251852     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7481.2     Document Type: Editorial

References (13)

1. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
2. Bulow S. Results of national registration of familial adenomatous polyposis. Gut 2003;52:742-6.
3. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
4. Lynch HT, Schuelke GS, Kimberling WJ, Albans WA, Lynch JF, Biscone KA, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Cancer 1985;56:939-51.
5. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Meddin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
6. Vasen HF, Mecklin JP, Meera Khan P, Lynch HT. non-polyposis colorectal cancer. Lancet 1991;338:877.
7. Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
8. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
9. Umar A, Boland CR, Terdiman J, Syngal S, de la Chapelle A, Ruschhoff J, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-7.
10. Jass JR. Pathology of hereditary nonpolyposis colorectal cancer. Ann N Y Acad Sci 2000;910:62-73.
11. Jarvinen H, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen L, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;118:829-34.
12. Elsaleh H, Shannon B, Iacopetta B. Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy. Gastroenterology 2001;120:1309-10.
13. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69-77.